|
Originally published In Press as doi:10.1074/jbc.M011637200 on April 30, 2001
J. Biol. Chem., Vol. 276, Issue 27, 25589-25597, July 6, 2001
A Novel Bipartite Intronic Splicing Enhancer Promotes the
Inclusion of a Mini-exon in the AMP Deaminase 1 Gene*
Thomas
Genetta ,
Hiroko
Morisaki§¶,
Takayuki
Morisaki§, and
Edward W.
Holmes **
From the Joseph P. Stokes Research Institute,
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, the § Department of Bioscience, National Cardiovascular
Center Research Institute, Suita, Osaka 565-0871, Japan, and the
School of Medicine, University of California at San Diego,
La Jolla, California 92093-0602
Alternative splicing of the 12-base exon 2 of the adenosine monophosphate deaminase (AMPD) gene is subject to
regulation by both cis- and trans-regulatory signals. The extent of
exon 2 inclusion is stage- and cell type-specific and is subject to the
physiological state of the cell. In adult skeletal muscle, a cell type
that regulates the activity of this allosteric enzyme at several
levels, the exon 2-plus form of AMPD, predominates. We have performed a
systematic analysis of the cis-acting regulatory sequences that reside
in the intron immediately downstream of this mini-exon. A complex
element comprising sequences that enhance exon 2 inclusion and
sequences that counteract this effect resides in the middle of this
intron. We demonstrate that the enhancing component is bipartite, with
more than a kilobase of sequence separating the two functional sites.
The presence of even minimal levels the mini-exon in the fully
processed AMPD mRNA requires both of these sites, neither of which
appears in any other published splicing enhancer. An RNA binding
activity derived from a muscle cell line requires both of the enhancing
sites. Mutations in either of the sites that eliminate exon 2 inclusion
abrogate this binding activity.
*
This work was supported in part by National Institutes of
Health Grant DK12314 (to E. W. H.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of a fellowship from the American Heart Association.
**
To whom correspondence should be addressed: Office of the Dean,
School of Medicine, University of California at San Diego, Rm. 1313 Basic Science Bldg., 9500 Gilman Dr., La Jolla, CA
92093-0602.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Sironi, G. Menozzi, G. P. Comi, R. Cagliani, N. Bresolin, and U. Pozzoli
Analysis of intronic conserved elements indicates that functional complexity might represent a major source of negative selection on non-coding sequences
Hum. Mol. Genet.,
September 1, 2005;
14(17):
2533 - 2546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Dredge and R. B. Darnell
Nova Regulates GABAA Receptor {gamma}2 Alternative Splicing via a Distal Downstream UCAU-Rich Intronic Splicing Enhancer
Mol. Cell. Biol.,
July 1, 2003;
23(13):
4687 - 4700.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|